Physician profile
Roman Isaac
NPI 1881913622
$1,506.46
in general payments reported to CMS, 2019-2025
11 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $326 · 2021: $16.02 · 2022: $115 · 2023: $301 · 2024: $459 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $881.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $633.74 | 2019-2024 | Healix Knotless Peek, Dynatape, Microfix Quickanchor Ethibond |
| Nevro Corp. | $172.88 | 2020-2022 | |
| Stryker Corporation | $141.32 | 2019-2024 | Variax, Gamma |
| Boston Scientific Corporation | $131.46 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $105.79 | 2025 | Breztri |
| Abbott Laboratories | $105.36 | 2020 | |
| Axogen | $84.44 | 2022-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Cap |
| Heron Therapeutics, INC. | $65.74 | 2023 | Zynrelef |
| Integra Lifesciences Corporation | $35.03 | 2019 | |
| Smith+Nephew, INC. | $16.02 | 2021 | |
| Endo Pharmaceuticals INC. | $14.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roman Isaac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.